Nalaganje...
No QTc Prolongation with Semaglutide: A Thorough QT Study in Healthy Subjects
INTRODUCTION: Semaglutide is a glucagon-like peptide-1 (GLP-1) analog approved for the once-weekly treatment of type 2 diabetes. The objective of this 16-week, double-blind, single-center thorough QT study was to confirm that semaglutide treatment does not prolong cardiac repolarization versus place...
Shranjeno v:
| izdano v: | Diabetes Ther |
|---|---|
| Main Authors: | , , , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Springer Healthcare
2018
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6064589/ https://ncbi.nlm.nih.gov/pubmed/29799100 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s13300-018-0442-0 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|